Literature DB >> 9204656

Octreotide may prevent definitive intestinal obstruction.

S Mercadante1, J Kargar, G Nicolosi.   

Abstract

Partial bowel obstruction is indistinguishable from definitive obstruction at the onset of symptoms. No consensus exists regarding the treatment of potentially reversible states of bowel obstruction. On the basis of previous experience, octreotide was used in two patients with chronic intestinal obstruction, resulting in good control of intestinal symptoms and maintenance of a prolonged adequate intestinal transit, preventing the occurrence of definitive bowel obstruction. The results observed stress the early use of octreotide in such delicate clinical situations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9204656     DOI: 10.1016/s0885-3924(97)00084-5

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  7 in total

Review 1.  [Pharmacological treatment of malignant bowel obstruction in severely ill and dying patients : a systematic literature review].

Authors:  C Klein; S Stiel; J Bükki; C Ostgathe
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

Review 2.  Treatment of non-pain-related symptoms.

Authors:  Charles F von Gunten; Ellin Gafford
Journal:  Cancer J       Date:  2013 Sep-Oct       Impact factor: 3.360

Review 3.  Modern management of cancer-related intestinal obstruction.

Authors:  M P Davis; C Nouneh
Journal:  Curr Oncol Rep       Date:  2000-07       Impact factor: 5.075

4.  Octreotide acetate successfully treated a bowel obstruction caused by peritoneally disseminated gastric cancer, thereby enabling the subsequent use of oral S-1 chemotherapy.

Authors:  Koshi Kumagai; Yoshiro Saikawa; Kazumasa Fukuda; Ryo Ito; Takahiro Igarashi; Shinichi Tsuwano; Rieko Nakamura; Tsunehiro Takahashi; Hiroya Takeuchi; Yuko Kitagawa
Journal:  Int J Clin Oncol       Date:  2009-08-25       Impact factor: 3.402

Review 5.  Recent advances in malignant bowel obstruction: an interface of old and new.

Authors:  Vinaya Potluri; Donna S Zhukovsky
Journal:  Curr Pain Headache Rep       Date:  2003-08

Review 6.  Modern management of cancer-related intestinal obstruction.

Authors:  M P Davis; C Nouneh
Journal:  Curr Pain Headache Rep       Date:  2001-06

7.  The use of lanreotide autogel® in the treatment of intestinal obstruction in a patient with adenocarcinoma.

Authors:  Willem Lybaert
Journal:  Case Rep Oncol       Date:  2014-01-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.